4.41 USD
+0.11 (+2.52%)
AT CLOSE (11:59 AM EDT)
Perspective Therapeutics, Inc. (CATX)
AMEX: CATX • USD
4.39
-0.02 (-0.50%)
POST MARKET (AS OF 08:15 PM EDT)
Market: CLOSED
Open?$4.28
High?$4.56
Low?$4.22
Prev. Close?$4.41
Volume?1.1M
Avg. Volume?1.7M
VWAP?$4.42
Rel. Volume?0.61x
Bid / Ask
Bid?$4.37 × 300
Ask?$4.42 × 100
Spread?$0.05
Midpoint?$4.40
Valuation & Ratios
Market Cap?502.4M
Shares Out?113.9M
Float?62.0M
Float %?83.4%
P/E Ratio?N/A
P/B Ratio?2.43
EPS?-$0.91
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.17Strong
Quick Ratio?5.17Strong
Cash Ratio?1.07Strong
Debt/Equity?0.01Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?2.43CHEAP▾
P/S?568.38HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.3CHEAP▾
EV/Sales?535.57HIGH▾
Returns & Efficiency
ROE?-49.8%WEAK▾
ROA?-38.6%WEAK▾
Cash Flow & Enterprise
FCF?$-95368000
Enterprise Value?$473.4M
Related Companies
Loading...
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Employees
166
Market Cap
502.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
SEATTLE, WA 98121
Phone: 206-676-0900